SCHEMBL30065768

SCHEMBL30065768

Nc1ccccc1-c1cncc(Nc2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 4/20 0.48
▸ SLC22A12 Q96S37 4/20 0.48
▸ ALDH1A1 P00352 6/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ MAPT P10636 4/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ ALOX12 P18054 2/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ PDPK1 O15530 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ PTGS2 P35354 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28063108 0.81 ALDH1A1 (0.64) ALDH1A1HSD17B10MAPTL3MBTL1ALOX12
SCHEMBL11757533 0.80 ALDH1A1 (0.56) ALDH1A1HSD17B10L3MBTL1CYP3A4ALOX15
SCHEMBL19268415 0.80 ALDH1A1 (0.57) ALDH1A1HSD17B10MAPTL3MBTL1ALOX12
SCHEMBL4192415 0.79 XDH (0.59) XDHSLC22A12ALDH1A1HSD17B10MAPT
Diphenylamine SCHEMBL21753932 0.79 ALDH1A1 (0.74) ALDH1A1HSD17B10MAPTL3MBTL1ALOX12
SCHEMBL2841435 0.76 MEN1 (0.56) XDHSLC22A12ALDH1A1MAPTL3MBTL1
SCHEMBL21915556 0.75 FDPS (0.56) XDHSLC22A12PIK3CBCNR1
SCHEMBL24137798 0.73 XDH (0.50) XDHSLC22A12MAPTCYP1A2CYP3A4
SCHEMBL30065759 0.73 XDH (0.41) XDHSLC22A12ALDH1A1HSD17B10CYP3A4
SCHEMBL4187260 0.72 XDH (0.63) XDHSLC22A12CYP3A4TSHRCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12351556-B2 Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2025-07-08 — — US disclosed
US-20220363643-A1 NOVEL PYRIDIN-2(1H)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN CENTRE HOSPITALIER UNIVERSITAIRE DE CLERMONT-FD (FR) 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363643-A1 NOVEL PYRIDIN-2(1H)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN P2RX3, OPRL1, P2RX6 XDH 1051/4885SLC22A12 3909/4885ALDH1A1 836/4885
US-12351556-B2 Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain P2RX3, P2RX6, P2RX4 XDH 938/4885SLC22A12 3755/4885ALDH1A1 809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback